Access to Primary Care and Endocrinology Care Among Medicare Beneficiaries With Type 1 and Type 2 Diabetes, 2017-2021.

Related in JClub

• Diabetes CareJClub

  Clinical Guidance for Disease-Modifying Immunotherapy in Children and Adolescents With New-Onset (Stage 3) Type 1 Diabetes.

  Diabetes Care · 11 Nov 2026 · Journal Article

  AI summary · may contain errors

  Teplizumab’s 2026 U.S. approval for children and adolescents aged 8–17 with new-onset stage 3 type 1 diabetes reshapes the first weeks after diagnosis.

  Open

  Share

  Copy linkPost on XPost on BlueskyShare on LinkedIn

  https://jclub.com.au/a/43012423

  Open in JClub
• Diabetes CareJClub

  Transient Cognitive Vulnerability After Hypoglycemia in Adults With Type 1 Diabetes: Evidence From Continuous Glucose Monitoring and Cognitive Ecologic Momentary Assessment.

  Diabetes Care · 10 Nov 2026 · Journal Article

  AI summary · may contain errors

  Hypoglycemic events in adults with type 1 diabetes occurring within 0–1 h before smartphone cognitive testing are linked to slower reaction time and poorer DSM and GCPT performance.

  Open

  Share

  Copy linkPost on XPost on BlueskyShare on LinkedIn

  https://jclub.com.au/a/43007282

  Open in JClub
• Diabetes CareJClub

  Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA Study.

  Diabetes Care · 2 Nov 2026 · Journal Article

  AI summary · may contain errors

  Lower fecal elastase-1 during the first 6 months of life predicts later multiple islet autoantibodies or type 1 diabetes in ENDIA children, with β-coefficients down to -0.61 at birth.

  Open

  Share

  Copy linkPost on XPost on BlueskyShare on LinkedIn

  https://jclub.com.au/a/42969688

  Open in JClub